These studies highlight the usefulness of humanized mice to study not only the antitumor effects of anti-PD-1 blockade but also the human immune responses to human tumors, as these studies revealed significant tumor growth suppression and antitumor CD8+ T cell responses following PD-1 blockade treatment. Here, CD8A is linked to neoplasm.